TScan Therapeutics, Inc. - COM (TCRX)

Q1 2022 13F Portfolio Holders as of 3/31/2022

Type / Class
Equity / COM
Number of holders
24
Total Shares
9.41M
Shares change
-455K
Total reported value, excl. options
$26.3M
Value change
-$1.5M
Put/Call ratio
0
Number of buys
12
Number of sells
-11
Price
$2.80
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.